Calidi Biotherapeutics Announces Proposed Public Offering
Portfolio Pulse from
Calidi Biotherapeutics, Inc. announced a proposed public offering of its common stock and/or pre-funded warrants. The company plans to sell all shares itself.
November 13, 2024 | 9:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Calidi Biotherapeutics is planning a public offering of its common stock and pre-funded warrants, which could impact its stock price.
The announcement of a public offering typically leads to a short-term decrease in stock price due to dilution concerns. As Calidi is selling all shares itself, this could increase the supply of shares in the market, potentially driving the price down.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100